Log in to save to my catalogue

Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast canc...

Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast canc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2b0e3db5c69b4345bac7835ff7078f9c

Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials

About this item

Full title

Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials

Publisher

England: BioMed Central Ltd

Journal title

Breast cancer research : BCR, 2021-03, Vol.23 (1), p.36-13, Article 36

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Prediction of histological tumor size by post-neoadjuvant therapy (NAT) ultrasound and magnetic resonance imaging (MRI) was evaluated in different breast cancer subtypes.
Imaging was performed after 12-week NAT in patients enrolled into three neoadjuvant WSG ADAPT subtrials. Imaging performance was analyzed for prediction of residual tumor measu...

Alternative Titles

Full title

Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2b0e3db5c69b4345bac7835ff7078f9c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2b0e3db5c69b4345bac7835ff7078f9c

Other Identifiers

ISSN

1465-542X,1465-5411

E-ISSN

1465-542X

DOI

10.1186/s13058-021-01413-y

How to access this item